Forecasting

Forecasting: Patient flow modeling comes of age

Judith Kulich, associate principal, and Emily Jin, manager, at ZS Associates talk to eyeforpharma about how patient flow modeling can inform forecasting read...
READ THE FULL ARTICLE >>

Understanding the utility of MPR

Kevin Cast, vice president, Curascript, explains how medication possession ratios (MPR) can improve forecasting and compliance read...
READ THE FULL ARTICLE >>

Forecasting for ‘pharmerging’ markets

Peter Mansell explores why new forecasting models and methods are needed as pharmaceutical companies increasingly turn to emerging markets to offset faltering growth. read...
READ THE FULL ARTICLE >>

Forecasting for orphan drugs: The data challenge

Gianclaudio Floria, senior manager for business planning and analysis at Amgen, on best practice in forecasting for orphan drug development. read...
READ THE FULL ARTICLE >>

Mal’s Musings: What’s Up with The Bottom Line?

Upon reflection, there are a number of misconceptions in business and many more ideas, concepts, and scenarios better categorized as bullsh_t.read...
READ THE FULL ARTICLE >>

Forecasting for complex diseases

Peter Mansell reports on how advances in molecular and cell biology are making the forecaster’s job more complex—and more business critical. read...
READ THE FULL ARTICLE >>

Forecasting: Does Wall St know something pharma doesn’t?

Andrew Tolve explores how pharma forecasters and Wall St analysts can improve their forecasts by learning from each other. read...
READ THE FULL ARTICLE >>

Forecasting the Middle Eastern market

Radi Haloub of the University of Huddersfield on Jordan as an entry point for the Middle Eastern pharma market. read...
READ THE FULL ARTICLE >>

Forecasting and total supply chain inventory

Joseph DeFeo, product director at IntegriChain, on how tracking retail inventory leads to better forecasting and increased transparency. read...
READ THE FULL ARTICLE >>

Forecasting the future of biosimilars

Charles Nau, director of federal affairs at Johnson and Johnson, on what's ahead for the biosimilars market. read...
READ THE FULL ARTICLE >>
Get Adobe Flash playerPlugin by wpburn.com wordpress themes